Degradation of a magnesium alloy stent in the rabbit abdominal aorta

doi:10.3969/j.issn.2095-4344.2017.18.013

Abstract

Abstract:

BACKGROUND: Foreign studies have found that the magnesium alloy stent is safe and effective, but there are few studies on the degradation performance of magnesium alloy stents in China.

OBJECTIVE: To investigate the degradation of degradable AZ31 magnesium alloy stent in the rabbit abdominal aorta and the effect of degradation process on vascularization.

METHODS: Twenty-eight rabbits were enrolled, and the degradable AZ31 magnesium alloy stent was implanted into the rabbit abdominal aorta. Postoperative abdominal aortic X-ray examination and histological observation were done at 30, 60, 90, 120 days after implantation.

RESULTS AND CONCLUSION: (1) X-ray examination: 30 days after implantation, the stent expanded completely with structural integrity; 60 days after implantation, the stent deformation, partial stent fracture, and lose of support were found; 90 days after implantation, only a small amount of support rod residues were found, and the majority of the stent was degraded; and 120 days after implantation, there was no support rod residual, and the stent was degraded completely. (2) Histological observation: 60 days after implantation, the number of residual support rods was less than that 30 days after implantation (P < 0.05), the number value at 90 days after implantation was lower than that at 30 and 60 days after implantation (P < 0.05), and the number value at 120 days after implantation was lower than that at 30, 60, 90 days after implantation (P < 0.05), indicating that the number of residual support rods was negatively correlated with post-implantation days. The time for complete stent degradation was 124.8 days. The intimal area at 90 days after implantation was higher than that at 30, 60, 120 days after implantation (P < 0.05), while the lumen area was smaller than that at 30, 60, 120 days after implantation (P < 0.05). There was no significant difference in the intimal area and lumen area at latter three time points after implantation. To conclude, the degradation of the degradable AZ31 magnesium alloy stent in the rabbit abdominal aorta can be completed within 124.8 days, and at 90 days after the stent is implanted, vascular intimal hyperplasia and lumen stenosis are most serious, and then gradually reduced.

中国组织工程研究杂志出版内容重点：生物材料；骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性；组织工程

Key words: Aorta, Abdominal, Tunica Intima, Tissue Engineering

CLC Number:

R318

An Qian, Cui Wen-jun, Si Jiang-tao, Wang Ying, Wu Fei, Ding Yu, Li Yang, Wang Bing.

Degradation of a magnesium alloy stent in the rabbit abdominal aorta [J]. Chinese Journal of Tissue Engineering Research, 2017, 21(18): 2864-2869.

Figures/Tables 2

References

[1]孙红刚,居克举,高社荣.颈动脉狭窄患者血管成形和支架植入术后血流动力学的改变[J].临床神经病学杂志, 2015,28(3): 229-231.

[2]郭素峡,羊镇宇,王如兴,等.不同支架植入方式对小血管支架内再狭窄的影响[J].心脏杂志,2011,23(6):786-789.

[3]王燕,段峰,李志伟,等.预防血管内支架植入术后再狭窄的研究进展[J].介入放射学杂志,2011,20(8):665-668.

[4]方海洋,项建,吴延庆.药物洗脱支架与血管内放射治疗在支架内再狭窄中运用的Meta分析[J].山东大学学报(医学版)2013,51(1): 56-63.

[5]刘军,朱中玉,高传玉,等.冠心病患者药物洗脱支架治疗后血管再狭窄临床分析[J].中华实用诊断与治疗杂志, 2013,27(6): 538-539,542.

[6]王天松,冯旭霞,姚震.药物洗脱支架置入术后支架内再狭窄的血管内超声观察[J].中国循环杂志,2013,28(5):348-351.

[7]Agasthi P,Aloor S,Menon V,et al.TCT-427 Comparison of Neointimal Coverage Patterns between Biodegradable Vascular Stentsand Drug Eluting Stents using Optical Coherence tomography: A Meta-Analysis.J Am Coll Cardiol. 2016;68(18S):B172-B173.

[8]皇甫强,袁思波,韩建业,等.生物可降解血管支架研究进展[J].中国材料进展,2015,34(5):396-400.

[9]赵丹阳,顿锁,田慧卿,等.生物可降解聚合物血管支架膨胀性能有限元分析[J].大连理工大学学报,2014,54(1):54-59.

[10]Sotomi Y,Ishibashi Y,Suwannasom P,et al.Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORBBiodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II Trial.JACC Cardiovasc Interv. 2016;9(12):1216-1227.

[11]张红梅,张利鹏.可降解血管支架材料的表面性能及生物相容性[J].中国组织工程研究,2016,20(43):6445-6450.

[12]Foin N,Torii R,Mattesini A,et al.Biodegradable vascular scaffold: is optimal expansion the key to minimising flow disturbances and risk of adverse events? EuroIntervention. 2015;10(10):1139-1142.

[13]李树新,杨巍.生物可降解镁合金支架在冠状动脉血管中应用进展[J].医学综述,2015,21(2):193-195.

[14]Ma J,Zhao N,Betts L,et al.Bio-Adaption between Magnesium Alloy Stent and the Blood Vessel: A Review.J Mater Sci Technol.2016;32(9):815-826.

[15]谭志刚,周倩,蒋宇钢.生物可降解镁合金血管支架:缺点及未来研究趋势[J].中国组织工程研究,2015,19(8):1284-1288.

[16]夏永辉,任玲,徐克,等.镁合金血管支架置入后内膜增生特点[J].介入放射学杂志,2014,23(2):132-135.

[17]Ning C,Zhou L,Zhu Y,et al.Influence of Surrounding Cations on the Surface Degradation of MagnesiumAlloy Implants under a Compressive Pressure.Langmuir.2015;31(50): 13561-13570.

[18]王武,程英升,李永东,等.可降解镁合金覆膜支架治疗兔颈总动脉侧壁型动脉瘤可行性研究[J].介入放射学杂志, 2016,25(2): 151-154.

[19]赵辉,雷民.新型可吸收镁合金支架在血管内应用及生物相容性[J].中国组织工程研究,2016,20(8):1165-1170.

[20]Yue Y,Wang L,Yang N,et al.Effectiveness of Biodegradable Magnesium Alloy Stents in Coronary Artery and Femoral Artery.J Interv Cardiol.2015;28(4):358-364.

[21]崔红凯,李奋保,张铭秋.生物可降解镁合金覆膜支架治疗兔颈内动脉动脉瘤的可行性分析[J].临床放射学杂志,2016,35(7): 1116-1120.

[22]Zhao N,Zhu D.Endothelial responses of magnesium and other alloying elements in magnesium-basestentmaterials. Metallomics.2015;7(1):118-128.

[23]杨金辉,陈晏晏.以专利技术申请信息分析生物可降解镁及镁合金血管支架的现状[J].中国组织工程研究, 2016,20(43): 6507-6513.

[24]Bastante T,Cuesta J,Rivero F,et al.Delayed fracture of a bioresorbable vascular scaffold implanted for in-stent restenosis.EuroIntervention.2017;12(13):1643.

[25]曾智桓,张仁丹,赵艳群,等.下调Slit/Robo通路抑制兔血管成形术后血管再狭窄[J].实用医学杂志,2016,32(12):1934-1937.

[26]Li Y,Tang L,Qi D,et al.Correlation between high perfusion syndrome and stent restenosis afterstent implantation.Exp Ther Med.2016;12(6):3675-3679.

[27]史作磊,王坤,于剑,等.血浆内皮素-1及NO对膝下动脉硬化闭塞症球囊扩张成形术后血管再狭窄的预测价值[J].中国现代普通外科进展,2015,18(2):127-129.

[28]Buszman PP,Michalak MJ,Pruski M,et al.Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model.Cardiol J.2016;23(6):657-666.

[29]巢雄杰,熊国祚.Caveolae/Caveolin-1影响PAD支架植入后血管再狭窄的作用与机制研究进展[J].现代医药卫生, 2015,31(14): 2124-2126.

[30]Lee WC,Fang HY,Fang CY.Late stent thrombosis after the use of a bioresorbable vascular scaffold for the treatment of in-stent restenosis.Coron Artery Dis.2016;27(8):709-710.

[31]Rizik DG,Hermiller JB,Kereiakes DJ.Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials.Catheter Cardiovasc Interv.2016;88(S1):21-30.

[32]熊筱伟,朱劲舟,杜润,等.聚合物涂层改性对药物洗脱支架植入后血管内膜修复的作用[J].介入放射学杂志, 2012,21(8): 655-659.

[33]Arafat A,Roselli EE,Idrees JJ,et al.Stent Grafting Acute Aortic Dissection: Comparison of DeBakey Extent IIIA Versus IIIB. Ann Thorac Surg.2016;102(5):1473-1481.

[34]杨源瑞,郑波,周振华,等.猪颈动脉支架植入术后PPAR-γ的表达变化及对血管平滑肌表型转化的影响[J].第三军医大学学报, 2014,36(4):321-325.

[35]Otto S,Jaeger K,Kolodgie FD,et al.A novel polymer-free ciglitazone-coated vascular stent: in vivo and ex vivo analysis of stentendothelialization in a rabbit iliac artery model. Oncotarget. 2016;7(36):57571-57580.

[36]胡德喜,陆东风,林刚毅.雷公藤内酯醇洗脱支架对小型猪冠状动脉内膜增生及细胞分裂周期基因2、基质金属蛋白酶2表达的影响[J].中国临床保健杂志,2014,17(4):380-383.

[37]Tesfamariam B.Bioresorbable vascular scaffolds: Biodegradation, drug delivery and vascular remodeling. Pharmacol Res.2016;107:163-171.

[38]Xu B,Zhang YJ,Sun ZW,et al.Comparison of long-term in-stent vascular response between abluminal groove-filled biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent: 3-year OCT follow-up from the TARGET I trial.Int J Cardiovasc Imaging. 2015;31(8): 1489-1496.

[39]高学忠,阿米娜•马合木提,黄隐青,等.功能性药物洗脱支架对冠状动脉介入治疗后内膜增生及TFPI-2的影响[J].中国动脉硬化杂志,2014,22(11):1101-1104.

[40]McDonald RA,Halliday CA,Miller AM,et al. Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation.J Am Coll Cardiol.2015;65(21): 2314-2327.

[41]Shih CM,Huang CY,Liao LR,et al.Nickel ions from a corroded cardiovascular stent induce monocytic cell apoptosis: Proposed impact on vascular remodeling and mechanism.J Formos Med Assoc. 2015;114(11):1088-1096.

[42]Pollock TM. Materials science. Weight loss with magnesium alloys.Science.2010;328(5981):986-987.

[43]Witte F, Fischer J, Nellesen J, et al. In vitro and in vivo corrosion measurements of magnesium alloys. Biomaterials. 2006;27(7):1013-1018.

[44]Wang HX,Guan SK,Wang X,et al.In vitro degradation and mechanical integrity of Mg-Zn-Ca alloy coated with Ca-deficient hydroxyapatite by the pulse electrodeposition process.Acta Biomater. 2010 ;6(5):1734-1738.